HB6895 - Defense Production and Active Pharmaceutical Ingredients Act
US Congress - 118th Congress
Last updated 9 months ago
0 Co-Sponsors
To amend the National Defense Authorization Act for Fiscal Year 2023 to extend Federal support for bioindustrial manufacturing processes to include support for the manufacturing of certain pharmaceutical ingredients.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now